A round-up of this week's top digital healthcare news. Marco Ricci reports.
Doubts fuelling a lack of excellence in digital healthcare?There is no doubt that digital is the way forward for... Read more
Biosimilars could save European and US healthcare systems billions - but more needs to be done to maximise their benefits, writes Richard Staines.
Richard StainesBiosimilars are becoming an ever-greater part of... Read more
After two giddy years of continuous growth, biotech got a rude awakening in late 2015, but many remain confident in the sector's growth potential, writes Andrew McConaghie.After two successive record-breaking... Read more
How well are pharma companies adapting to the digital age? Susan Macdonald speaks to three experts in the field about what they see as the challenges and opportunities.
In this... Read more
Sanofi has said it will continue pursuing cancer drug firm Medivation after the US company rejected a $9.3 billion unsolicited takeover offer.
Medivation said its board had unanimously rejected the offer... Read more
Gilead and Janssen's possible HIV blockbuster, Odefsey (emtricitabine+rilpivirine+tenofovir alafenamide) has been given the green light by Europe's top regulatory committee.The CHMP backed Odefsey, the second drug recommended by the committee... Read more
Facing US generic competition to its cholesterol drug Crestor next week, AstraZeneca is cutting costs and pinning its hopes on a wave of new cancer drugs.In a Q1 results statement AstraZeneca said guidance for... Read more
Biosimilar manufacturers are awaiting guidance from US and EU regulators which could help stimulate uptake and development of these near-copy biologic medicines.
Despite a US law creating an abbreviated development pathway for biosimilars... Read more
Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world. These heightened... View info
Marking Rare Disease Day this week, Boehringer Ingelheim UK’s report Inspiration is a collaboration between patients, patient groups and leading clinicians with the aim of putting IPF in the spotlight... View info
It is impossible to seduce or a delicious dinner, no new postures, and you do not have the patience to put up with having sex once a week? Try Generic Cialis - Often it happens that because of their age or for other reasons, men lose their potency, and against the background of everyday affairs, interest in his personal life is gradually fading. The disease is or penalty for excessive activity at a young age, it's up to you! With Generic Viagra treatment you will keep your potency at the highest level!